| Dr Jessica Marie Boudreaux, DO | |
|
1542 Tulane Ave., Lsuhsc Dept. Of Psychiatry Room 233, New Orleans, LA 70112-0000 | |
| (504) 568-7912 | |
| Not Available |
| Full Name | Dr Jessica Marie Boudreaux |
|---|---|
| Gender | Female |
| Speciality | Student In An Organized Health Care Education/training Program |
| Location | 1542 Tulane Ave., New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427381599 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | UO2160 (Florida) | Secondary |
| 390200000X | Student In An Organized Health Care Education/training Program | (Louisiana) | Primary |
| Entity Name | East Louisiana State Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043206543 PECOS PAC ID: 6002853835 Enrollment ID: O20050413000902 |
News Archive
A research team at the University of California, Riverside School of Medicine has identified a pathway involving astrocytes, a class of central nervous system support cells, that could shed light on why seizures happen in a subset of multiple sclerosis, or MS, patients.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the second quarter ended June 30, 2010.
Minimally invasive surgical techniques have revolutionized the treatment paraesophageal hernia-but there's continued controversy over some key technical aspects of the procedure.
Industry Standard Research (ISR Reports) today announced the launch of a substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
Congenital heart disease is the most common form of birth defect, affecting one out of every 125 babies, according to the National Institutes of Health. Researchers from the University of Missouri recently found success using a drug to treat laboratory mice with one form of congenital heart disease, hypertrophic cardiomyopathy - a weakening of the heart caused by abnormally thick muscle.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jessica Marie Boudreaux, DO 1542 Tulane Ave., Lsuhsc Dept Of Psychiatry Room 233, New Orleans, LA 70112 Ph: (504) 568-7912 | Dr Jessica Marie Boudreaux, DO 1542 Tulane Ave., Lsuhsc Dept. Of Psychiatry Room 233, New Orleans, LA 70112-0000 Ph: (504) 568-7912 |
News Archive
A research team at the University of California, Riverside School of Medicine has identified a pathway involving astrocytes, a class of central nervous system support cells, that could shed light on why seizures happen in a subset of multiple sclerosis, or MS, patients.
Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced its financial results for the second quarter ended June 30, 2010.
Minimally invasive surgical techniques have revolutionized the treatment paraesophageal hernia-but there's continued controversy over some key technical aspects of the procedure.
Industry Standard Research (ISR Reports) today announced the launch of a substantial research report titled Success in Patient and Investigator Recruitment. This report presents data and analysis from 362 interviews with Patients, Principal Investigators, and Drug development professionals from around the world.
Congenital heart disease is the most common form of birth defect, affecting one out of every 125 babies, according to the National Institutes of Health. Researchers from the University of Missouri recently found success using a drug to treat laboratory mice with one form of congenital heart disease, hypertrophic cardiomyopathy - a weakening of the heart caused by abnormally thick muscle.
› Verified 1 days ago